Summit Therapeutics (NASDAQ:SMMT) Director Buys $9,999,982.58 in Stock
MarketBeat
Summit Therapeutics PLC (NASDAQ:SMMT - Get Free Report) Director Yu Xia purchased 533,617 shares of the firm's stock in a transaction dated Tuesday, October 21st. The stock was acquired at an average cost of $18.74 per share, for a total transaction of $9,999,982.58. Following the purchase, the director owned 32,057,147 shares in the company, valued at approximately $600,750,934.78. The trade was a 1.69% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link.
NASDAQ:SMMT